Developmental Funds

发展基金

• 批准号: 7991463
• 负责人: Harvey R. Herschman
• 金额: $ 19.02万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2015-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7991463
• 关键词: Animal Model; Comprehensive Cancer Center; Development; Diagnosis; Funding; Goals; Image; Malignant Neoplasms; Molecular; Monitor; Progress Reports; Publications; Research; Research Personnel; Resources; Rome; Technology; anticancer research; cancer imaging; in vivo Cellular and Molecular Imaging Centers; medical schools; molecular imaging; pre-clinical

Since this submission is a competitive renewal, we will first present a brief Background to describe how our Developmental Funds have been/will be used. We support four Developmental Fund Projects annually, at $45-50K per project. Projects are for up to two years; second year funding competes in the pool with first year funding applicafions. Our initial goal for our Developmental Funds was to facilitate introduction of molecular imaging to UCLA cancer research; to bring the strongest molecular, cellular and cancer researchers into the imaging arena and to proselytize for use of non-invasive imaging in fundamental cancer research. In our current funding cycle, three of the four Research component Projects were new, and grew out of Developmental Funds Projects. Funding our competing ICMIC renewal is perhaps the best objective testimony that we achieved our goal. The narratives below describe proposed Developmental Fund Projects for year 1 of the renewal application. During this current cycle, the Jonsson Comprehensive Cancer Center and the Dean for Research for the David Geffen School of Medicine have also contributed funds to support related projects, in consultafion with Dr. Herschman (for details see Secfion A, Description).

由于此提交是一次竞争性续订，我们将首先介绍一个简短的 描述我们的发展基金已经/将如何使用的背景。我们支持四个 发展基金年度项目，每个项目45000-50000美元。项目的期限最长为两年；第二年的资金与第一年的资金申请在池中竞争。我们最初的目标是 发展基金是为了促进将分子成像引入加州大学洛杉矶分校的癌症研究；将最强大的分子、细胞和癌症研究人员带入成像领域，并倡导在基础癌症研究中使用非侵入性成像。在我们目前的资助周期中，四个研究组成部分项目中有三个是新的，由发展基金项目发展而来。资助我们相互竞争的ICMIC更新也许是我们实现目标的最好的客观证明。下面的说明描述了续展申请第一年的拟议发展基金项目。 在本周期内，琼森综合癌症中心和大卫·格芬医学院研究主任也为相关项目提供了资金，并与赫希曼博士进行了磋商(详情见Secfion A，Description)。